The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1361
Potassium Iodide for Thyroid Protection in a Nuclear Accident
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.

Even though it is unlikely that people living in the US will be at risk of significant radiation exposure from the nuclear accident in Japan, some readers have suggested a review of the use of potassium iodide (KI) in such circumstances. Potassium iodide taken orally before or at the time of exposure can limit or prevent uptake of radioactive iodine by the thyroid gland.

EXPOSURE TO RADIOACTIVE IODINE — A breach-of-containment nuclear reactor accident at a functioning nuclear power plant can release radioactive iodine and other radionuclides. Human exposure can result from inhalation of iodine particles or aerosols, or from ingestion of contaminated water, vegetation, dairy products or meat; grazing cows that feed on radioactive iodine-contaminated vegetation secrete radioactive iodine in their milk. Children, adolescents and young adults who as children were exposed to even small amounts of radioactive iodine from ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Potassium Iodide for Thyroid Protection in a Nuclear Accident
Article code: 1361b
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian